Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective

J G Bessems1, N P Vermeulen

  • 1Leiden/Amsterdam Center for Drug Research, Department of Pharmacochemistry, Vrije Universiteit, Amsterdam, The Netherlands.

Insights

Paracetamol (acetaminophen) toxicity involves molecular bioactivation and detoxication pathways. Understanding these mechanisms aids in developing chemoprotective agents and safer drug analogues.

Area of Science:

  • Toxicology
  • Pharmacology
  • Molecular Biology

Background:

  • Paracetamol (acetaminophen) is a common analgesic with known toxicity.
  • Its toxicity is linked to molecular mechanisms including bioactivation and detoxication.
  • Understanding these pathways is crucial for drug safety and development.

Purpose of the Study:

  • To provide an overview of the molecular aspects of paracetamol toxicity.
  • To discuss bioactivation, detoxication, chemoprevention, and chemoprotection.
  • To explore clinical and pharmacological aspects of paracetamol toxicity.

Main Methods:

  • Review of molecular mechanisms of paracetamol toxicity.
  • Detailed description of Phase I and Phase II biotransformation pathways.
  • In-depth analysis of hepatotoxicity and renal toxicity mechanisms.

Main Results:

  • Hepatotoxicity involves covalent protein binding, oxidative stress, and nuclear effects.
  • Renal toxicity is associated with prostaglandin synthase, N-deacetylase, cytochrome P450, and glutathione S-transferase.
  • Species differences in metabolism and interorgan transport are significant.

Conclusions:

  • Molecular understanding of paracetamol toxicity informs the development of chemoprotective strategies.
  • Progress is being made in designing structural analogues with improved therapeutic indices.
  • Further research into nuclear effects and secondary events may reveal new therapeutic targets.

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...